Kinnate Biopharma
KNTE
$2.65
Share price
0.00%
Change (1 day)
-38.37%
Change (1 year)
Categories
Kinnate Biopharma (KNTE) - Cash on Hand
Cash on Hand as of December 2023 : $0.15 B
According to Kinnate Biopharma's latest financial reports the company has $0.15 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Kinnate Biopharma - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.20 B | -8.19% |
| 2021-12-31 | $0.21 B | -44.7% |
| 2020-12-31 | $0.39 B | 419.09% |
| 2019-12-31 | $76.45 M | 992.34% |
| 2018-12-31 | $6.99 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.31 B | 105.65% | 🇺🇸 USA |